Rockwell Medical (NASDAQ:RMTI) Upgraded at StockNews.com

StockNews.com upgraded shares of Rockwell Medical (NASDAQ:RMTI) from a hold rating to a buy rating in a research note published on Thursday.

A number of other equities research analysts have also weighed in on RMTI. RODMAN&RENSHAW raised Rockwell Medical to a “strong-buy” rating in a research note on Thursday, November 14th. HC Wainwright lowered their price objective on Rockwell Medical from $9.00 to $7.00 and set a “buy” rating for the company in a research report on Monday, November 25th. Finally, Rodman & Renshaw started coverage on Rockwell Medical in a research note on Thursday, November 14th. They set a “buy” rating and a $5.00 price objective for the company.

Rockwell Medical Stock Performance

Rockwell Medical stock opened at $2.04 on Thursday. The firm has a fifty day simple moving average of $3.03 and a two-hundred day simple moving average of $2.69. The company has a quick ratio of 2.00, a current ratio of 2.41 and a debt-to-equity ratio of 0.33. Rockwell Medical has a twelve month low of $1.16 and a twelve month high of $5.15. The company has a market capitalization of $65.93 million, a PE ratio of -40.80 and a beta of 1.38.

Institutional Trading of Rockwell Medical

A number of institutional investors have recently modified their holdings of the company. Barclays PLC bought a new position in shares of Rockwell Medical during the third quarter valued at approximately $90,000. XTX Topco Ltd grew its holdings in shares of Rockwell Medical by 45.7% during the 3rd quarter. XTX Topco Ltd now owns 28,455 shares of the company’s stock worth $113,000 after acquiring an additional 8,922 shares during the period. Jane Street Group LLC purchased a new position in shares of Rockwell Medical in the 3rd quarter valued at approximately $534,000. State Street Corp boosted its position in shares of Rockwell Medical by 21.5% during the third quarter. State Street Corp now owns 95,004 shares of the company’s stock valued at $377,000 after purchasing an additional 16,800 shares in the last quarter. Finally, HighTower Advisors LLC grew its stake in Rockwell Medical by 75.6% in the third quarter. HighTower Advisors LLC now owns 57,413 shares of the company’s stock worth $228,000 after purchasing an additional 24,715 shares during the period. 23.31% of the stock is currently owned by hedge funds and other institutional investors.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.